Brimonidine Tartrate 0.025%

DRUG4 trials

Sponsors

Eye Therapies, LLC, Bausch & Lomb Incorporated

Conditions

Allergic ConjunctivitisGlaucoma and Ocular HypertensionOcular Redness

Phase 1

Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT01687426

Eye Therapies, LLCGlaucoma and Ocular Hypertension

Start: 2012-09-30End: 2012-12-31Updated: 2012-12-25

Phase 2

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

CompletedNCT01275105

Eye Therapies, LLCAllergic Conjunctivitis

Start: 2011-01-31End: 2011-03-31Updated: 2012-03-06

Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

CompletedNCT01675609

Eye Therapies, LLCOcular Redness

Start: 2012-08-31Updated: 2014-07-31

Phase 3

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

CompletedNCT05579730

Bausch & Lomb IncorporatedAllergic Conjunctivitis

Start: 2022-10-12End: 2023-07-22Updated: 2025-02-14